Drug Type TCR-T Cell therapy |
Synonyms Autologous Nectin-4-solid tumor program (TCR2 Therapeutics), Nectin-4-targeted TRuC-T (TCR2 Therapeutics) |
Target |
Action modulators |
Mechanism nectin-4 modulators(Nectin-4 modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Solid tumor | Discovery | United Kingdom | 01 May 2022 |





